-
0days
-
0Hours
-
0Minutes
Welcome and Opening Remarks John Collings
President, Asia Pacific | Chairman | Stryker | APACMed
Keynote Address Dr. Vinod Kumar Paul
Member, NITI Aayog | Government of India
Keynote Address by Guest of Honour Smt. Anupriya Patel
Hon'ble Minister of State for Health & Family Welfare and Chemicals & Fertilizers | Government of India
Inaugural Address by Chief Guest (Video Message) Shri Jagat Prakash Nadda
Hon’ble Union Minister of Health and Family Welfare and Chemicals & Fertilizers | Government of India
Global MedTech CEO's unpack why India is a top-priority market and what’s shaping boardroom decisions, where the biggest opportunities lie, and what it takes to succeed in one of the world’s most dynamic healthcare markets.
Gary Steven Guthart
Executive Chair, Intuitive Surgical Board of Directors | Intuitive
Kevin Lobo
Chair and CEO | Stryker
Katarzyna Mazur-Hofsäß
CEO Care Enablement & Member of the Management Board | Fresenius Medical Care
Shereen Bhan
Managing Editor | CNBC-TV18
This session will examine the key enablers for India's transformation to a global MedTech powerhouse, spanning innovation, regulatory excellence, talent development, infrastructure, and global market access, and outline strategies to unlock India’s full MedTech potential and position it as a global leader.
Keynote Address Shri Amit Agrawal
Secretary, Department Of Pharmaceuticals | Government of India
Session Moderator Anirudh Roy Popli
Partner | McKinsey & Company
Panellist Feng Dong
Vice President, Asia Region-Led Markets, EurAsia | Medtronic
Panellist Himanshu Baid
Managing Director | Poly Medicure
Panellist Varun Khanna
Group Managing Director | Quality Care India Limited
Panellist Sujay Mashru
Senior Vice President, APAC & Growth Markets | LivaNova
This session explores how India can nurture a multi-level innovation ecosystem that balances incremental advancements with long-cycle, high-risk, high-reward innovation, supported by policy, infrastructure, and talent to transition from being a MedTech consumer to a MedTech creator and exporter.
Keynote Address Dr. Rajiv Bahl
Secretary, Dept of Health Research & DG, ICMR | Government of India
Keynote Address Dr. Parvinder Maini
Scientific Secretary, Office of PSA | Government of India
Session Moderator Vijay Chawla
Partner & Chief Operating Officer – Consulting, Head – Life Sciences | KPMG India
Panellist Slobodan Radumilo
Sr. Vice President & President International | Embecta
Panellist Vishnu Kalra
Company Group Chairman | Johnson & Johnson MEDTech, Asia Pacific
Panellist Dilip Jose
Managing Director & CEO | Manipal Health Enterprises
Panellist Vivek Shah
Chief Executive Officer | Meril Lifesciences
The session will address the important question: "How can India bridge the gap between innovative medical devices and expanded access to healthcare technologies, ensuring that global breakthroughs are available to every citizen?” and define actionable pathways for ensuring that MedTech innovation translates into real-world healthcare access across India.
Session Moderator Joydeep Ghosh
Partner and Life sciences and healthcare industry leader, Deloitte South Asia | Deloitte
Panellist Shri C K Mishra
Former Secretary, Health, Environment, Forest & Climate Change | Government of India
Panellist Probir Das
Group Chief Executive Officer | Integris MedTech
Panellist Viren Shetty
Vice Chairman | Narayana Health
Panellist Dr. Sandeep Wadhwa
Global Chief Medical Officer, Health Information Systems | Solventum
Panellist Kaustav Banerjee
CEO | Alkem MedTech
This session will delve into how Indian MedTech companies are tapping into private equity and public markets to scale operations, advance local manufacturing, and forge global partnerships. Experts from investment banking, private equity, and strategic advisory will unpack the financial and strategic levers accelerating this transformation.
Keynote Address Shri BVR Subrahmanyam
Chief Executive Officer, NITI Aayog | Government of India
Session Moderator Karan Singh
Chairman | Bain & Company India
Panellist Dr. Upasana Arora
Managing Director | Yashoda Super Speciality Hospitals
Panellist Sandeep Wasan
Managing Director, APAC Healthcare Investment Banking | Citi
Panellist Anish Bafna
Managing Director and CEO | Healthium Medtech Limited
Panellist Dr. Shravan Subramanyam
Managing Director BPL Medical Technologies | Group CEO Claypond Capital MedTech Platform
Panellist Himanshu Nema
Managing Director | Warburg Pincus
Welcome Harjit Gill
Chief Executive Officer | Asia Pacific Medical Technology Association (APACMed)
Keynote Address Ms Nivruti Rai
Managing Director & CEO | Invest India
This session will unpack the promise, challenges and path forward for AI in MedTech with perspectives from government and industry (local and global). Speakers will explore key themes of AI tools deployment across MedTech, the vision of a unified data source, governing AI’s usage in healthcare and upskilling the healthcare workforce to work with AI.
Opening Remarks Rahul Sharma
Managing Director | US-India Business Council (USIBC)
Session Moderator Kushe Bahl
Partner, Mumbai | McKinsey & Company
Panellist Robert Cohen
Vice President, Innovation and Technology, Orthopaedics Group | Stryker
Panellist Carla Cartwright
Head Global Digital and Regulatory Policy | Johnson & Johnson
Panellist Dr Sujoy Kar
Chief Medical Information Officer, Vice President | Apollo Hospitals
This session will explore how regulatory agility is becoming a critical enabler of innovation in the MedTech sector. As technologies like AI, digital health, and personalized medicine rapidly evolve, traditional regulatory pathways must adapt to ensure timely patient access without compromising safety. This session will feature leading regulators and industry experts as they share real-world examples of how regulatory frameworks are evolving to keep pace with disruption.
Session Moderator Daniel Moelands
Vice President, Regulatory Affairs, APAC | Johnson & Johnson MedTech
Panellist Dr Muralitharan Paramasua
Chief Executive Officer, Medical Device Authority (MDA) | Ministry of Health Malaysia
Panellist Christopher Lam
Regulatory Consultant, Medical Devices Cluster, Health Products Regulation Group | Singapore Health Sciences Authority (HSA)
Panellist John Jamieson
Assistant Secretary of the Medical Devices Authorisation Branch | Australia Therapeutic Goods Administration (TGA)
Panellist Shri Aseem Sahu
Deputy Drugs Controller (India), Medical Device Division | Central Drugs Standard Control Organization
As India cements deeper strategic and economic ties with the U.S., UK, and EU, it is rapidly emerging as a pivotal player in the future of MedTech. This session convenes policymakers, industry leaders, and global experts to explore how India’s evolving trade, innovation, and regulatory frameworks are reshaping its role on the world stage. From high-value manufacturing to cross-border R&D, we’ll examine how bilateral corridors can unlock India’s full potential as a global MedTech powerhouse.
Session Moderator Nivedita Mehra
Managing Director | US-India Strategic Partnership Forum (USISPF)
Panellist Shri Tarun Bajaj
Former Revenue and Economic Affairs Secretary, and Chairman | US India Tax Forum
Panellist Bhargav Kotadia
Managing Director & CEO | Sahajanand Medical Technologies Ltd.
Panellist Oliver Bisazza
Chief Executive Officer | MedTech Europe
Panellist LaMont Bryant
Vice President, Global Government Affairs and Market Access | Stryker
As India targets Universal Health Coverage by 2030, its expanding medical device market plays a critical role in advancing equitable healthcare. This session will explore how reimbursement reforms can drive sustainable market growth and improve patient access to innovative technologies across the country.
Session Moderator Ashish Rampuria
Partner, Healthcare | Deloitte
Panellist Dr. Bollineni Bhaskar Rao
Chairman and Managing Director | KIMS Group of Hospitals
Panellist Paul Delatore
Vice President & Global Head, Market Access | Alcon
Panellist Shishir Agarwal
President and Managing Director | Terumo India
Panellist Gurmit Singh Chugh
Chairman & Founder | Translumina Theurapeutics
Panellist Dr. Abhitabh Gupta
Chief Business Executive | Ace Insurance Brokers Pvt. Ltd.
This session will explore strategies to expand access to advanced diagnostics in Tier 2 and 3 regions by strengthening the ecosystem—enabling regulatory environment, improving IT infrastructure, workforce capabilities, and supply chain efficiencies. Discussions will focus on bridging gaps through healthcare decentralization from manufacturing to last-mile delivery to enable timely and equitable diagnosis.
Session Moderator Sumit Goel
Partner, Management Consulting, Healthcare | PWC India
Panellist Dr Nivedita Gupta
Scientist G & Head. Communicable Diseases (CD), Division, ICMR | Government of India
Panellist Saurabh Rajadhyax
Sr. Vice President Clinical Operations, Asia Pacific | bioMérieux
Panellist Ravi Sinha
Managing Director, Core Lab | Abbott Healthcare
Panellist Shankha Banerjee
Chief Executive Officer | Dr Lal PathLabs
Panellist Harkesh Dabas
Managing Director | William J Clinton Foundation, India
Innovation in MedTech has transformative potential to advance the delivery of healthcare. It also raises significant legal and ethical considerations given the pace of change. This session will explore the key themes of regulatory compliance, data privacy and protection, cybersecurity, and the criticality of training and education in enabling effective adoption of new technologies and their associated risks.
Session Moderator Pritpal S. Sodhi
Partner | EY India
Panellist Basel AbouJalala
Senior Vice President and General Manager – Emerging Markets | Smith + Nephew
Panellist Kunal Gupta
Partner | Trilegal
Panellist Madan Krishnan
Vice President & Managing Director Asia Pacific Growth Markets | Boston Scientific
Panellist Rami Rajab
CEO | Mecomed
Panellist Prof Nirmal Kumar Ganguly
President | Apollo Hospitals Educational and Research Foundation
Panellist Gunjan Singh
Director - Compliance, Clinical Affairs – India; Compliance Divisional Liaison: NV-APAC | Stryker